Pronexus Analytical Preclinical Contract Research Organisation

Pronexus Analytical is a preclinical contract research organisation (CRO) offering advanced services in pharmacology of the central nervous system (CNS), neurochemistry and neurophysiology. Pronexus’ core expertise is focused on in vivo techniques for monitoring neurotransmitter release and metabolism, animal models of CNS disorders, PK/PD studies and testing the implantable medical devices and drug delivery systems.

Collectively, we have more than 75 years of research experience in CNS pharmacology, proof-of-concept studies and evaluation of mechanisms of drug actions using microdialysis and related bioanalytical techniques, biosensors and electrophysiological recordings.

Bioanalytical services

The bioanalytical services include high-sensitive HPLC techniques and immunoassays for determination of neurotransmitters and other neuroactive molecules, as well as metabolites and drug levels in the microdialysis samples, plasma, CSF, cell lysates and brain tissue extracts. The bioanalytical laboratory and the animal research facility are GLP-compliant with full regulatory approvals. All services provided by Pronexus Analytical are carried out under strictly professional non-disclosure agreements.

Experimental models of CNS disorders

  • Microsurgery, stereotaxic surgery on small laboratory animals – implantation of injection/infusion cannulas including microdialysis probes, catheters and CSF/blood sampling
  • Pharmacokinetics and monitoring drug delivery at the target site – acute or chronic administration regimens, drug delivery through BBB, targeted bioavailability, syringe minipumps based continuous/discontinuous drug infusions for up to four weeks and Alzet osmotic minipumps
  • Microdialysis protocols on anesthetised or awake rats and mice – "proof-of-concept" studies of candidate drugs (CDs), monitoring neurotransmitters and other surrogate markers and correlation to behaviour
  • Simultaneous microdialysis and behavioral monitoring, phenotyping – behavioral models of CNS disorders: schizophrenia, depression, anxiety, ADHD, Parkinson’s disease and cognitive dysfunction
  • Lesion models of neurodegenerative disorders – 6-OHDA, MPTP-lesion models of Parkinson’s disease, 192IgG-saporin lesions of cholinergic neurons, ibotenic acid lesions and similar models
  • Biosensors – fast monitoring of glutamate release – recordings of tonic and phasic L-glutamate levels in anesthetised or awake rats, focus on Glu transporters; NMDA, mGluR2/3 and mGluR5 receptors
  • Electrophysiological recordings in brain slices – role of ionotropic (NMDA, AMPA, kainite) and metabotropic receptors on modulating EPSPs
  • Phenotyping of transgenic mice – physiological tests, behavioral methods and biochemical/neurochemical markers

Bioanalytical services and determination of surrogate markers

Pronexus Analytical provides determination of biomolecules in microdialysis samples, tissue extracts, plasma, CSF, urine and other body fluids:

  • Ultra-sensitive detection of monoamines – the most sensitive assay available and developed especially for simultaneous determination of noradrenaline, dopamine and serotonin down to 10-11M [100atmol/20µl] and for histamine [300atmol/20µl]
  • HPLC techniques optimised for determination of neurotransmitters, neuromodulators and related molecules in the microdialysates. Serotonin, noradrenaline, dopamine and their metabolites, acetylcholine, GABA, aspartate and glutamate, glycine, physiological amino acids, histamine, adenosine and other purines, cAMP, cGMP, kynurenic acid, radical oxygen species (ROS), NO2/NO3, Mg2+, Ca2+ and other ions
  • HPLC and LC/MS methods for analysis of biological samples – determination of specified biomolecules or drugs in plasma, CSF and tissue extracts.
  • HPLC and enzymatic spectrophotometric assays for clinical microdialysates – amino acid analysis, lactate, pyruvate, glycerol, glucose, enzymes and clinical biomarkers
  • Enzyme immunoassays
  • Development and validation of HPLC methods

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

New Whitepaper from Pronexus Analytical: Neurochemical In Vivo Monitoring and Allied Bioanalytical Techniques

Pronexus Analytical is a preclinical contract research organisation that offers services in neurochemical in vivo monitoring and allied bioanalytical techniques. Pronexus Analytical's new, free-to-download whitepaper outlines the company's services in this area. Click

White Papers

Pronexus Analytical – Neurochemical In Vivo Monitoring and Allied Bioanalytical Techniques

Pronexus Analytical - Neurochemical In Vivo Monitoring and Allied Bioanalytical Techniques

Address
Pronexus Analytical AB

Karolinska Science Park

Fogdevreten 2a

Stockholm

171 77

Other

Sweden

www.pronexus.se

Pronexus Analytical Images

Products and Services

Video

Press Release

22 April 2010

Pronexus Analytical is a preclinical contract research organisation that offers services in neurochemical in vivo monitoring and allied bioanalytical techniques. Pronexus Analytical's new, free-to-download whitepaper outlines the company's services in this area. Click Read more

10 February 2010

Dr Jan Kehr, CEO of Pronexus Analytical and the senior scientist at Karolinska Institutet, Stockholm, Sweden, has been invited to give a lecture entitled: "Monitoring brain neurotransmission and metabolism by in vivo microdialysis: A historical overview and future perspectives", at the next In Vi

Read more

Regional Offices

Pronexus Analytical AB

Karolinska Science Park

Fogdevreten 2a

Stockholm

171 77

Other

Sweden

www.pronexus.se

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.